# reload+after+2024-01-22 16:43:58.233815
address1§10900 Wilshire Blvd
address2§Suite 600
city§Los Angeles
state§CA
zip§90024
country§United States
phone§310 388 6706
website§https://www.chromadex.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.
fullTimeEmployees§113
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Frank Louis Jaksch Jr.', 'age': 55, 'title': 'Co-Founder & Chairman', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 292273, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robert N. Fried', 'age': 63, 'title': 'CEO & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 735544, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Brianna  Gerber', 'age': 42, 'title': 'Chief Financial Officer', 'yearBorn': 1981, 'fiscalYear': 2022, 'totalPay': 509816, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Andrew  Shao Ph.D.', 'title': 'Senior Vice President of Global Regulatory & Scientific Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Heather  Van Blarcom', 'title': 'Senior VP of Legal & Corporate Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Alex  Worsham', 'title': 'Vice President of Global Marketing & Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Kroes', 'title': 'Senior Vice President of People Matters', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Chu  Yan', 'title': 'Managing Director of Asia Pacific', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason  Campbell', 'title': 'Senior Vice President of Business Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§5
compensationRisk§6
shareHolderRightsRisk§2
overallRisk§4
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.793
priceToSalesTrailing12Months§1.3156006
currency§USD
dateShortInterest§1702598400
forwardEps§0.0
exchange§NCM
quoteType§EQUITY
shortName§ChromaDex Corporation
longName§ChromaDex Corporation
firstTradeDateEpochUtc§1214400600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§77342014-e7f0-3894-9d34-bbc3f6ead2f8
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§2.0
targetMeanPrice§4.85
targetMedianPrice§5.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§1.657
grossMargins§0.59804
ebitdaMargins§-0.06956
trailingPegRatio§None
